Judge Mulls Revival Of Nexium Pay-For-Delay Row

Law360, New York (March 7, 2014, 6:37 PM EST) -- A Massachusetts federal judge on Friday requested further briefing on whether he should reconsider portions of an order that granted victories to drugmakers Ranbaxy Inc. and Teva Pharmaceutical Industries Ltd. in a pay-for-delay class action involving the heartburn drug Nexium.

U.S. District Judge William G. Young denied a flurry of motions for reconsideration stemming from his multi-pronged Feb. 12 order, but laid out an expedited briefing schedule with regard to a pair of direct purchaser class plaintiffs' motions to give the Teva and Ranbaxy summary judgment...
To view the full article, register now.